23 Recruiting Chronic Myeloid Leukemia Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Chronic Myeloid Leukemia
Top Recruiting Chronic Myeloid Leukemia Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
📍 Baylor College of Medicine- McNair Campus — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
📍 The University of Chicago — Chicago, Illinois
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Olverembatinib (HQP1351) in Patients With CP-CML
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
📍 Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔